pard3

pard3

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">pard3</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PARD3</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Partitioning Defect 3 (Par-3)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10p11.21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>56243</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>609923</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8TEW0</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000116198</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,526 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~160 kDa</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Source</td>
</tr>
<tr>
<td class="label">PARD3 expression</td>
<td>Brain tissue</td>
</tr>
<tr>
<td class="label">Phospho-PARD3</td>
<td>CSF</td>
</tr>
<tr>
<td class="label">Genetic variants</td>
<td>Blood</td>
</tr>
<tr>
<td class="label">Polarity complex proteins</td>
<td>CSF</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

pard3

Overview

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">pard3</th>
</tr>
<tr>
<td class="label">Feature</td>
<td>Details</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PARD3</td>
</tr>
<tr>
<td class="label">Gene Name</td>
<td>Partitioning Defect 3 (Par-3)</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>10p11.21</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>56243</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>609923</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td>Q8TEW0</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000116198</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>1,526 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~160 kDa</td>
</tr>
<tr>
<td class="label">Biomarker</td>
<td>Source</td>
</tr>
<tr>
<td class="label">PARD3 expression</td>
<td>Brain tissue</td>
</tr>
<tr>
<td class="label">Phospho-PARD3</td>
<td>CSF</td>
</tr>
<tr>
<td class="label">Genetic variants</td>
<td>Blood</td>
</tr>
<tr>
<td class="label">Polarity complex proteins</td>
<td>CSF</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

The PARD3 gene (Partitioning Defect 3) encodes a core component of the PAR3/PAR6/aPKC (Par) polarity complex, one of the most fundamental and evolutionarily conserved protein complexes regulating cell polarity. In neurons, PARD3 plays essential roles in neuronal migration during development, axon specification, dendritic arborization, synapse formation, and synaptic plasticity. The Par complex establishes and maintains cellular asymmetry through spatially restricted protein localization and phosphorylation of downstream targets[@humbert2020][@par3_dev].

Cell polarity is fundamental to neuronal function, as neurons are highly polarized cells with distinct axonal and dendritic compartments. The proper establishment and maintenance of this polarity is essential for correct neuronal connectivity and circuit formation. Dysregulation of polarity complexes has been increasingly recognized as a contributor to neurodegenerative disease pathogenesis, making PARD3 an important molecule for understanding brain function and disease[@kim2019].

Gene and Protein Structure

Genomic Organization

The PARD3 gene spans approximately 95 kb on chromosome 10p11.21 and consists of 26 exons encoding a protein of 1,526 amino acids with a molecular weight of approximately 160 kDa. The gene produces multiple alternatively spliced isoforms with tissue-specific expression patterns.

Protein Domains

PARD3 contains multiple functional domains that mediate its interactions within the polarity complex[@windows2018]:

Biological Functions

The PAR3/PAR6/aPKC Complex

PARD3 functions as a central scaffold within the Par polarity complex[@inoue2018][@shi2020]:

The Par complex is evolutionarily conserved and functions in:

• Epithelial cell polarity
• Neuronal polarity
• Asymmetric cell division
• Cell migration

Neuronal Migration

During brain development, PARD3 regulates neuronal migration[@chen2019]:

Axon Specification

PARD3 is critical for axon/dendrite specification during neuronal differentiation:

Dendritic Development

Beyond axon specification, PARD3 regulates dendritic development[@zhou2019]:

Synaptic Plasticity

In mature neurons, PARD3 continues to function at synapses[@par3_synapse]:

Cell Junction Regulation

PARD3 regulates cell-cell junctions[@yang2018]:

Molecular Mechanisms

Phosphorylation Events

PARD3 activity is regulated by phosphorylation:

1. aPKC-mediated Phosphorylation

• aPKC phosphorylates PARD3 at specific serine/threonine sites
• Phosphorylation regulates PARD3's interactions with other proteins
• Controls the localization and stability of PARD3

• GSK3beta phosphorylates PARD3 in a context-dependent manner
• Affects PARD3's role in neuronal polarity
• Links polarity signaling to metabolic pathways

Protein-Protein Interactions

PARD3 interacts with numerous proteins:

• PAR6 (PARD6A/B/G): Core polarity complex member
• aPKC (PRKCI/Z): Kinase that phosphorylates PARD3
• Tight junction proteins: OCLN, TJP1
• Adherens junction proteins: CDH1, CTNNB1
• Cytoskeletal proteins: Actin, microtubule regulators

Disease Associations

Intellectual Disability and Autism

PARD3 dysfunction is associated with neurodevelopmental disorders[@liu2020][@mori2021]:

Schizophrenia

PARD3 may contribute to schizophrenia through:

Alzheimer's Disease

Emerging evidence links PARD3 to AD[@kim2019]:

Amyotrophic Lateral Sclerosis (ALS)

PARD3 involvement in ALS includes:

Axonal Injury and Regeneration

PARD3 plays a role in neural injury and repair[@zhang2019]:

Expression Patterns

Tissue Distribution

PARD3 is expressed in:

• Brain: Highest expression in developing and adult brain
• Epithelial tissues: Polarized epithelial cells
• Endothelial cells: Vascular endothelial cells
• Testis: Germ cells during development

Brain Expression

In the nervous system:

• Developing brain: High expression during embryogenesis
• Adult brain: Maintained expression in specific regions
• Neuronal subtypes: Particularly high in cortical and hippocampal neurons
• Glia: Expression in astrocytes and oligodendrocytes

Therapeutic Implications

Target Validation

PARD3 represents a potential therapeutic target:

Challenges

• Complex functions make targeting challenging
• Cell-type and developmental stage specificity required
• Balancing multiple functions within the polarity complex
• Delivery to the central nervous system

Preclinical Approaches

• Development of polarity-modulating small molecules
• Gene therapy approaches to restore PARD3 function
• Peptide-based interventions targeting protein interactions
• Cell-based therapies using polarity-enhanced neurons

Interaction Network

Core Polarity Complex

• PAR6 (PARD6A/B/G) — binding partner
• aPKC (PRKCI/PRKCZ) — kinase partner
• DLG1 — scaffolding protein
• LIN7A/B/C — additional polarity proteins

Downstream Effectors

• GSK3beta — polarity signaling
• LKB1 (STK11) — upstream kinase
• Rho GTPases — cytoskeletal regulation
• N-cadherin — cell adhesion

Animal Models

Knockout Mice

Pard3 knockout mice show[@assmann2019]:

• Embryonic lethality in complete knockouts
• Brain development abnormalities in conditional knockouts
• Neuronal migration defects
• Polarity disruption
• Behavioral abnormalities

Transgenic Models

Transgenic mice with altered Pard3 demonstrate:

• Altered neuronal connectivity
• Behavioral abnormalities
• Synaptic dysfunction
• Memory deficits

Research Directions

Key Unanswered Questions

Emerging Research Areas

• Single-cell analysis of polarity complex in disease
• Structure-function studies of PARD3 domains
• High-throughput screening for polarity modulators
• Patient-derived models

Neurodegenerative Disease Mechanisms

Alzheimer's Disease Pathogenesis

The involvement of PARD3 in Alzheimer's disease represents an emerging area of research with significant implications for understanding disease progression and developing therapeutic interventions. The connections between polarity complex dysfunction and AD pathology span multiple mechanistic domains.

Amyloid-beta Impact on Polarity Complexes

Amyloid-beta (Aβ) oligomers, the primary toxic species in AD pathogenesis, exert profound effects on neuronal polarity machinery. Research demonstrates that Aβ exposure disrupts the normal localization and function of PAR complex proteins[@kim2019]:

The consequences include impaired neuronal polarity, disrupted synapse formation, and enhanced vulnerability to degeneration. The polarity complex normally organizes synaptic protein trafficking, and its dysfunction contributes to the synaptic loss that correlates with cognitive decline in AD.

Tau Pathology and Polarity

Hyperphosphorylated tau, the component of neurofibrillary tangles, affects PARD3 function through multiple mechanisms:

Therapeutic Implications

Targeting PARD3 and the polarity complex offers potential therapeutic strategies:

Parkinson's Disease Connections

Emerging research suggests PARD3 may be involved in Parkinson's disease through several mechanisms:

Dopaminergic Neuron Vulnerability

PARD3 plays critical roles in dopaminergic neuron development and maintenance:

Alpha-synuclein Interactions

The relationship between alpha-synuclein pathology and polarity complexes is an emerging research area:

Therapeutic Potential

Modulating PARD3 function may offer benefits in PD:

Amyotrophic Lateral Sclerosis

PARD3 involvement in ALS encompasses several mechanistic domains:

Motor Neuron Polarity

Motor neurons are highly polarized cells requiring precise polarity for function:

Axonal Transport and Polarity

The relationship between axonal transport and polarity:

Neurodevelopmental Disorders

Beyond neurodegenerative diseases, PARD3 is critically involved in neurodevelopmental disorders:

Intellectual Disability Mechanisms

PARD3 mutations cause intellectual disability through specific mechanisms:

Autism Spectrum Disorder Connections

PARD3 dysfunction contributes to autism through:

Molecular Signaling Pathways

GSK3beta Signaling

PARD3 interactions with GSK3beta represent a key regulatory axis:

GSK3beta Phosphorylation of PARD3

downstream Effects

Rho GTPase Regulation

PARD3 interacts with Rho family GTPases:

RhoA Signaling

Rac1 and Cdc42

LKB1-AMPK Pathway

PARD3 connects to metabolic sensing pathways:

LKB1 (STK11) Regulation

AMPK Effects

Clinical Perspectives

Biomarkers

PARD3-related biomarkers are being developed:

Therapeutic Approaches

Small Molecule Modulators

Gene Therapy

Cell-Based Therapies

Animal Models and Research Tools

Genetic Models

Knockout Approaches

Phenotypic Analysis

In Vitro Systems

Cross-Links

• Related Proteins: [PAR6](/proteins/par6-protein), [aPKC](/proteins/prkci-protein), [PARD3B](/genes/pard3b), [DLG4](/proteins/dlg4-protein)
• Related Mechanisms: [Cell Polarity](/mechanisms/cell-polarity), [Neuronal Development](/mechanisms/neuronal-development), [Synaptic Plasticity](/mechanisms/synaptic-plasticity), [Axon Guidance](/mechanisms/axon-guidance)
• Related Diseases: [Intellectual Disability](/diseases/intellectual-disability), [Autism](/diseases/autism), [Alzheimer's Disease](/diseases/alzheimers-disease), [ALS](/diseases/amyotrophic-lateral-sclerosis)

References